Wing-Wai Wong

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn, Juan Sierra Madero, José Ramón Arribas et al. · The Lancet · 2018 · 381 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus–1 Infection: Week 48 Results of the DRIVE-AHEAD Trial

Chloe Orkin, Kathleen Squires, Jean‐Michel Molina et al. · Clinical Infectious Diseases · 2018 · 168 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

The TREAT Asia HIV Observational Database

Jialun Zhou, N. Kumarasamy, Rossana Ditangco et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2005 · 149 citations

Public Health, Health Sciences, Infectious Diseases +14

Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia.

Chung-Hsu Lai, Hsin‐Pai Chen, Te-Li Chen et al. · PubMed · 2004 · 129 citations

Life Sciences, Infectious Diseases, Microbiology +12

Late Presentation into Care of HIV Disease and Its Associated Factors in Asia: Results of TAHOD

Su Jin Jeong, Claire M. Italiano, Romanee Chaiwarith et al. · AIDS Research and Human Retroviruses · 2015 · 80 citations · Full text

Public Health, Geriatric Medicine, Epidemiologic Methods +14